(N-((S)-3(2-amino-2oxo-1,1diphenylethyl)pyrrolidin-1-yl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: 2-8°C
Hazard: Refer MSDS for complete information.
(N-((S)-3(2-amino-2oxo-1,1diphenylethyl)pyrrolidin-1-yl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl Product Information
(N-((S)-3(2-amino-2oxo-1,1diphenylethyl)pyrrolidin-1-yl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Darifenacin. The product is supplied by Clearsynth under CAT No. CS-O-31174.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
(N-((S)-3(2-amino-2oxo-1,1diphenylethyl)pyrrolidin-1-yl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl
CAT No.
CS-O-31174
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C47H51BrN4O3
Molecular Weight
799.83
Category
API Family
Storage Condition
2-8°C
Purity by HPLC
>98%
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
(N-((S)-3(2-amino-2oxo-1,1diphenylethyl)pyrrolidin-1-yl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl is supplied with detailed characterization data compliant with regulatory guideline. (N-((S)-3(2-amino-2oxo-1,1diphenylethyl)pyrrolidin-1-yl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Darifenacin.
Overview
"(S)-N-[3(S)-(2-Amino-2-oxo-1,1-diphenylethyl)pyrrolidin-1-yl]methyl-2-[1[2-(2,3-dhydrobenzofuran-5-ylethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide is an impurity of Darifenacin , a medication used to treat urinary incontinence.;Impurity in commercial preparations of Darifenacin"
Synonyms
"N-{[n-1-yl]methyl}-2-{1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenomide"
Application Notes
"(S)-N-[3(S)-(2-Amino-2-oxo-1,1-diphenylethyl)pyrrolidin-1-yl]methyl-2-[1[2-(2,3-dhydrobenzofuran-5-ylethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide is an impurity of Darifenacin , a medication used to treat urinary incontinence.;Impurity in commercial preparations of Darifenacin"
References
NULL
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.
Related Darifenacin Products
Darifenacin Oxidized Impurity
Darifenacin Pyrrolidin Carboxylic Acid Impurity
Darifenacin nitroso impurity
Darifenacin Carboxylic Acid Impurity
Darifenacin Dehydro Impurity
Darifenacin acid
Darifenacin-d4 Hydrochloride
Darifenacin Impurity B
Darifenacin Impurity 10 (Tartarate salt)
